# Turning Point Therapeutics, Inc.

Turning Point Therapeutics, Inc. is a company headquartered in San Diego, CA, United States.

## Company overview

- **Legal name:** Turning Point Therapeutics, Inc.
- **Former names in filing history:** TP Therapeutics, Inc. (2018-10-30 to 2018-10-30); TP Therapeutics, INC (2014-01-06 to 2017-05-25)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** San Diego, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001595893

## About

Turning Point Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001595893, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2022-02-28, it reported annual revenue of USD 30,829,000; net income of USD -236,551,000; total assets of USD 1,003,463,000 for the fiscal period ended 2021-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2021 (period ended 2021-12-31)

- **Revenue:** $30.8M (USD 30,829,000)
- **Net income:** -$236.6M (USD -236,551,000)
- **Total assets:** $1.0B (USD 1,003,463,000)
- **Cash and equivalents:** $427.9M (USD 427,879,000)
- **Operating cash flow:** -$153.9M (USD -153,885,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $25.0M (USD 25,000,000)
- **Net income:** -$157.3M (USD -157,292,000)
- **Total assets:** $1.1B (USD 1,136,713,000)
- **Cash and equivalents:** $554.1M (USD 554,101,000)
- **Operating cash flow:** -$82.8M (USD -82,793,000)

### FY2019 (period ended 2019-12-31)

- **Net income:** -$72.1M (USD -72,131,000)
- **Total assets:** $422.2M (USD 422,202,000)
- **Cash and equivalents:** $48.2M (USD 48,188,000)
- **Operating cash flow:** -$57.8M (USD -57,757,000)
- **Later filings:** Operating cash flow: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2022-08-17 — period 2022-08-17 — 8-K
- Form 8-K — filed 2022-08-08 — period 2022-08-08 — 8-K
- Form 10-Q — filed 2022-08-08 — period 2022-06-30 — 10-Q
- Form 8-K — filed 2022-06-24 — period 2022-06-23 — 8-K
- Form 8-K — filed 2022-06-21 — period 2022-06-16 — 8-K
- Form 8-K — filed 2022-06-03 — period 2022-06-02 — 8-K
- Form 8-K — filed 2022-06-03 — period 2022-06-02 — 8-K
- Form 10-Q — filed 2022-05-10 — period 2022-03-31 — 10-Q
- Form 8-K — filed 2022-05-10 — period 2022-05-10 — 8-K
- Form 8-K — filed 2022-05-05 — period 2022-05-05 — 8-K
- Form DEF 14A — filed 2022-04-29 — period 2022-06-16 — DEF 14A
- Form 8-K — filed 2022-04-13 — period 2022-04-13 — 8-K

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/turning-point-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology